impurity_table
TL3 Analytical chemist · Zürich, CH
I keep the impurity reference tables. Named, unnamed, and "unspecified" are three different regulatory categories and it matters.
Joined 3 November 2024 · last posted 1h · groups: analytical-chemists, wiki-editors
138 posts, newest first. Showing up to 150.
-
What consumer-accessible tests can and cannot determine Replied, post #3 · Analytics › Home & field testing · 28 Jul 2026 · 0 likes Confirming the opening post from a second method, which matters more than confirming it from a second person. Molecular tests: DNA or RNA tests are not applicable to…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #85 · Clinical › Prescriber conversations · 27 Jul 2026 · 3 likes Post #83 and I disagree about the size of the effect, not about the direction. Prescription logistics: confirm whether it will be filled locally, requires mail order,…
-
A site rotation scheme that is easy enough to actually follow Replied, post #126 · Practice › Administration · 27 Jul 2026 · 0 likes Drawing up with one needle and injecting with another: a reasonable practice if you have extra needles. Fresh needle for injection reduces tissue drag and can decrease…
-
Common supplements people ask about, assessed one at a time Replied, post #85 · Practice › Interactions · 23 Jul 2026 · 21 likes Worth separating two things that post #81 runs together. The most useful thing anyone has posted about common supplements in this category was a table of what had been…
-
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #48 · Compounds › Secretagogues & GH axis · 18 Jul 2026 · 2 likes Narrowing post #45, because the general version has more than one answer. Evidence quality in the secretagogue literature is honestly weaker than in the incretin…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #75 · Analytics › Impurities & related substances · 14 Jul 2026 · 1 like Narrowing post #74, because the general version has more than one answer. Relative response factors mean impurities are not detected in proportion to how much of them…
-
Submitting a sample: the process end to end Replied, post #79 · Sourcing › Independent verification · 13 Jul 2026 · 25 likes It does not extend to lots nobody has seen, it is not a recommendation, and it says nothing about anything other than what was measured. I have said this before in a…
-
Packaging that arrived damaged: documenting it properly Replied, post #40 · Sourcing › Logistics · 11 Jul 2026 · 15 likes Documentation after arrival: photograph the parcel and its contents on arrival. If something later turns out wrong (damage, loss, wrong item) you have evidence of the…
-
Revisiting: How this community labels and discusses unrefereed work Replied, post #20 · Evidence › Preprints · 10 Jul 2026 · 0 likes Second this, and I would have said it less carefully.
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #96 · Start Here › How to Ask · 4 Jul 2026 · 0 likes That is the distinction I keep failing to hold on to. Written down now.
-
Spreadsheets: an appreciation — what changed since Replied, post #89 · Lounge › Off topic · 3 Jul 2026 · 0 likes My understanding of Spreadsheets is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep repeating it.
-
What a certificate commits its issuer to — one year on Replied, post #100 · Analytics › COA interpretation · 1 Jul 2026 · 3 likes Marking my place. If it changes for me I will come back and say so.
-
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #17 · Compounds › Secretagogues & GH axis · 1 Jul 2026 · 1 like Taking Reading a rodent study seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled comparison,…
-
Tracking intake honestly when appetite is absent Replied, post #79 · Nutrition & Training › Protein & intake · 30 Jun 2026 · 0 likes Fibre and fluid tend to fall alongside protein when intake drops, and the constipation reported here follows from that as much as from the mechanism.
-
Heart failure with preserved ejection fraction: symptom endpoints Replied, post #11 · Clinical › Comorbidities · 27 Jun 2026 · 3 likes Post #8 answers the question as asked. The question underneath it is different. Bariatric surgery history: altered anatomy after surgery affects absorption. That…
-
Splitting an overlong document into two Replied, post #28 · Documentation › Wiki requests · 26 Jun 2026 · 16 likes The strongest case for a new document is a question that recurs and has a good answer buried in a reply. That is the promotion criterion as written.
-
Pages past their review date, listed — does this still hold? Replied, post #26 · Meta › Wiki maintenance · 26 Jun 2026 · 15 likes I had written a reply contradicting post #22 and deleted it. Here is what survived. Outdated external links: if a maintained page links to external sources and those…
-
Coming back to: A structured critique template this community uses Replied, post #35 · Evidence › Study critique · 16 Jun 2026 · 0 likes Adding a small correction to the structured critique template summary above rather than a disagreement with it. The substance holds; one of the figures is out by a…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #76 · Compounds › Semaglutide · 11 Jun 2026 · 22 likes On the injection-day question: the labelling for licensed semaglutide allows the day to be changed provided at least two days separate the two injections. That interval…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #130 · Practice › Storage & stability · 10 Jun 2026 · 32 likes I changed my mind about reconstituted after someone here asked me for the source and I could not produce one. That is worth saying out loud because it is the ordinary…
-
Second pass at: Absence of evidence and evidence of absence Replied, post #15 · Research Methods › Statistics · 4 Jun 2026 · 5 likes Confounding: a third variable explains an apparent association. In randomised data, randomisation balances confounders. In observational data, confounders can be…
-
Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #16 · Compounds › Semaglutide · 3 Jun 2026 · 20 likes I had written a reply contradicting post #14 and deleted it. Here is what survived. Nobody has said the unglamorous part of semaglutide formulation yet, so: most of the…
-
Does dual agonism explain the effect size, or is it dose? Replied, post #6 · Compounds › Tirzepatide · 29 May 2026 · 8 likes The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on satiety and energy expenditure, but how much of tirzepatide's effect is that and how…
-
Racemisation and why it is invisible to a mass measurement — what changed since Replied, post #8 · Analytics › Impurities & related substances · 27 May 2026 · 1 like Fair, and the limits you put on it are the part I will remember.
-
What to include when your question involves a chromatogram — one year on Replied, post #15 · Start Here › How to Ask · 25 May 2026 · 0 likes I had written a reply contradicting post #11 and deleted it. Here is what survived. Questions you cannot explain: "I cannot say why I am asking this, but is this…
-
A checklist for reading a certificate in under two minutes Replied, post #24 · Analytics › COA interpretation · 20 May 2026 · 32 likes Understood, and I withdraw the assumption I opened with.
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #61 · Practice › Reconstitution · 19 May 2026 · 0 likes Adding the measurement that post #58 says would settle it. Add the diluent down the side of the vial rather than directly onto the cake. It is slower and it avoids the…
-
Mood changes: monitoring, and when to involve a professional — what changed since Replied, post #9 · Wellbeing › Mental health · 16 May 2026 · 0 likes Worth separating two things that post #6 runs together. The published trials collected mood data and the interpretation is contested. Being precise about what was…
-
Batch numbers that do not match the vial label — what changed since Replied, post #13 · Sourcing › Red flags · 13 May 2026 · 11 likes Understood. Thank you for being specific about the limits of it.
-
About the Interactions category Replied, post #8 · Practice › Interactions · 10 May 2026 · 1 like Narrowing post #7, because the general version has more than one answer. Mechanistic reasoning about interactions has a poor predictive record. It is a good way to…
-
Two scans six weeks apart on different machines: a cautionary tale Replied, post #9 · Outcomes › Body composition · 30 Apr 2026 · 29 likes Post #6 answers the question as asked. The question underneath it is different. Bone mineral density changes with substantial weight loss are measurable and slow, and…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #104 · Practice › Interactions · 28 Apr 2026 · 0 likes Post #101 is the version of this I will quote in future. One addition. The most defensible general position in this subcategory: identify the plausible mechanism, check…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #43 · Compounds › Semaglutide · 25 Apr 2026 · 0 likes Counterpoint on molecular mass of semaglutide, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled the…
-
About the Announcements category Replied, post #4 · Meta › Announcements · 15 Apr 2026 · 13 likes Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #102 · Regional › UK & Ireland · 2 Apr 2026 · 0 likes Taking post #99 at face value and following it one step further. Two sentences on pharmacy supply and then I will stop, because the rest is speculation and the thread…
-
Revisiting: Drawing up with one needle and injecting with another Replied, post #12 · Practice › Administration · 1 Apr 2026 · 30 likes Post #8 put the caveat in the right place and I want to underline it. Injecting slowly is worth doing for volume rather than for chemistry. Larger volumes delivered…
-
The "under review" status pill and when a moderator applies it Replied, post #47 · Evidence › Preprints · 31 Mar 2026 · 1 like What changes between preprint and publication: authors respond to reviewer comments, re-analyse data, correct errors found in peer review, and sometimes report…
-
The anatomy of a question that gets answered within an hour Replied, post #7 · Start Here › How to Ask · 29 Mar 2026 · 22 likes I had written a reply contradicting post #3 and deleted it. Here is what survived. A photograph of a vial is rarely useful and a photograph of a document usually is.…
-
A plateau that disappeared when I changed how I measured Replied, post #24 · Outcomes › Progress reports · 17 Mar 2026 · 3 likes I read post #20 twice before replying, because I had assumed the opposite. Practical answer on plateau, since the theoretical one is upthread: do the simplest check…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #18 · Compounds › Repair & healing peptides · 6 Mar 2026 · 12 likes If you are new and reading this thread for the answer to Stability of BPC-157: the answer is conditional, the conditions are in the third reply, and the rest of the…
-
Manufacturer assistance programmes and their eligibility rules Replied, post #9 · Access › Pricing · 5 Mar 2026 · 6 likes Where I have landed on manufacturer assistance programmes, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a…
-
[2026 update] What a purity-only report leaves out Replied, post #36 · Sourcing › Independent verification · 26 Feb 2026 · 2 likes Purity-only: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and I would like to know…
-
Measurement error in a self-reported exposure Replied, post #26 · Evidence › Study critique · 23 Feb 2026 · 28 likes What would change my mind on measurement error is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say…
-
Non-inferiority margins: how they are chosen and how they are abused — a second dataset Replied, post #36 · Evidence › Trials · 23 Feb 2026 · 5 likes I read post #32 twice before replying, because I had assumed the opposite. The failure mode on Non-inferiority margins is boring rather than dramatic. It is almost…
-
Amylin receptor signalling and satiety — what changed since Replied, post #33 · Pharmacology › Receptor biology · 20 Feb 2026 · 28 likes Worth separating two things that post #29 runs together. One caution on Amylin receptor signalling and satiety: everything above assumes the underlying documentation is…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #32 · Practice › Dosing & titration · 16 Feb 2026 · 0 likes Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure, half-life, receptor selectivity, and in what has been…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #104 · Analytics › Mass spectrometry · 15 Feb 2026 · 1 like Post #101 describes the usual case. This is about the unusual one. Deamidation adds approximately one dalton and produces a species that frequently elutes very close to…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #54 · Evidence › Study critique · 15 Feb 2026 · 0 likes I had written a reply contradicting post #52 and deleted it. Here is what survived. Hold a trial to the standard something could actually have met. A criticism that no…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #108 · Access › International · 14 Feb 2026 · 1 like Licensed prescribing: where a compound is approved, prescribing is restricted to licensed prescribers. Where it is not approved, the legality of possession and use is…
-
Distinguishing a red flag from an inconvenience Replied, post #3 · marked as the solution · Sourcing › Red flags · 9 Feb 2026 · 14 likes Inconsistency across documents: a certificate stating one purity, a website claiming another, and a supplier's verbal representation claiming a third, all on the same…
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #40 · Practice › Reconstitution · 6 Feb 2026 · 2 likes I read post #36 twice before replying, because I had assumed the opposite. I have no financial interest in anything named in this thread and I want to say so before I…
-
Constipation management, with a dietitian's contribution Replied, post #23 · Practice › Side effects · 26 Jan 2026 · 0 likes Constipation is reported at least as often as nausea and is discussed a fraction as much. Fluid, fibre and movement are the boring answers and they are the ones that…
-
A single out-of-range value on an otherwise normal panel Replied, post #8 · Clinical › Bloodwork · 25 Jan 2026 · 17 likes A request rather than an answer: could whoever has the primary source for single out-of-range value post it? I have seen the claim three times this month and each…
-
Request declined, with reasoning — what changed since Replied, post #7 · Meta › Feature requests · 21 Jan 2026 · 0 likes Post #4 answers the question as asked. The question underneath it is different. Request with a caveat attached: a compare view for two vendor pages side by side. The…
-
Guidelines revision: what changed and why — one year on Replied, post #60 · Meta › Announcements · 19 Jan 2026 · 19 likes The rare case here is the one that costs somebody a week, though, and the common case costs everyone ten seconds. I think the trade is clearly correct.
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #13 · Clinical › Special populations · 13 Jan 2026 · 11 likes The useful distinction on pregnancy and pregnancy planning is between what was measured and what was inferred from it. Both end up in the same sentence and only one of…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #12 · Data & Tools › Datasets · 6 Jan 2026 · 2 likes Small methodological point on community side-effect dataset: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
-
Personal import allowances, compared — a second dataset Replied, post #46 · Access › International · 3 Jan 2026 · 0 likes Licensed prescribing: where a compound is approved, prescribing is restricted to licensed prescribers. Where it is not approved, the legality of possession and use is…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #118 · Practice › Side effects · 30 Dec 2025 · 0 likes The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Started this topic · Practice › Administration · 14 Dec 2025 · 3 likes Rotating between abdomen, thigh and upper arm: absorption differences — one year on — setting out what I have, and where I think it stops being reliable. Asking about…
-
Lyophilisation and why the cake looks the way it does Replied, post #29 · Pharmacology › Formulation chemistry · 12 Dec 2025 · 0 likes Aggregation is concentration-dependent, which is why reconstituting to a high concentration is not always the convenient choice it appears to be. It reads as pedantry…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #50 · Compounds › Tirzepatide · 7 Dec 2025 · 24 likes What I can speak to on Tirzepatide in type 2 diabetes is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #66 · Analytics › Home & field testing · 30 Nov 2025 · 7 likes On post #62 — agreed on the reasoning, with one qualification. Research-use-only material is not certified for anything by anybody, and no home procedure changes that.…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #82 · Compounds › Other compounds · 25 Nov 2025 · 15 likes Answering the question post #79 raises rather than the one it answers. Naming conventions for research peptides cause confusion because suppliers do not follow a…
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #66 · Practice › Reconstitution · 25 Nov 2025 · 16 likes Dead volume is the part nobody mentions until it costs them a dose. A fixed-needle insulin syringe holds very little; a detachable-needle luer configuration can hold…
-
What pooling buys you and what it destroys Replied, post #73 · Evidence › Meta-analyses · 22 Nov 2025 · 0 likes Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be…
-
[2026 update] What steady state means for the decision to escalate Replied, post #94 · Practice › Dosing & titration · 15 Nov 2025 · 25 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.
-
Pharmaceutical compounding rules, summarised from primary sources — a second dataset Replied, post #27 · Sourcing › Regulatory · 12 Nov 2025 · 0 likes Checked the Pharmaceutical compounding rules claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #58 · Start Here › How to Ask · 4 Nov 2025 · 0 likes Noted, and I have changed what I was going to do on the strength of it.
-
What pooling buys you and what it destroys Replied, post #42 · Evidence › Meta-analyses · 14 Oct 2025 · 21 likes Having read the whole pooling buys thread before replying: the question in the first post has not actually been answered yet, and three of us have answered a nearby one…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #47 · Lounge › Off topic · 20 Sep 2025 · 0 likes That is true everywhere. The reference material that gets used is the material that answers a question you have at the moment you have it, and glamour has nothing to do…
-
Which panel is worth repeating and which is worth ignoring Replied, post #109 · Clinical › Bloodwork · 12 Sep 2025 · 17 likes Answering the panel question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends on how the first…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #54 · Practice › Administration · 9 Sep 2025 · 19 likes Pinching a fold is useful for lean tissue and unnecessary elsewhere. The point is to keep the needle out of muscle, and whether you need to depends on the site and on…
-
Journal club: STEP-HFpEF and symptom endpoints — a second dataset Replied, post #8 · Evidence › Journal club · 6 Sep 2025 · 0 likes Noted, and thank you for writing it out rather than summarising it.
-
A ten-fold dose error caught before injection Replied, post #92 · Devices › Syringes & needles · 1 Sep 2025 · 21 likes U-100 means the barrel is graduated for a solution containing one hundred units of insulin per millilitre. For anything that is not insulin, the units are simply…
-
Guidelines revision: what changed and why — one year on Replied, post #10 · Meta › Announcements · 24 Aug 2025 · 1 like I read post #8 twice before replying, because I had assumed the opposite. Trying to state the Guidelines revision position in a way that someone who disagrees would…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #13 · Practice › Side effects · 24 Aug 2025 · 0 likes Building on post #12 rather than restating it. The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #42 · Evidence › Journal club · 24 Aug 2025 · 7 likes Nothing to add, except that this is the answer I would give if asked.
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #29 · Compounds › Oral incretins · 19 Aug 2025 · 25 likes Nothing to add, except that this is the answer I would give if asked.
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #38 · Analytics › HPLC & UHPLC · 16 Aug 2025 · 25 likes Building on post #35 rather than restating it. Retention time is only comparable within a laboratory on a given method. Quoting a retention time across two reports as…
-
What this community means by "a source", in practical terms Replied, post #72 · Start Here › Welcome · 15 Aug 2025 · 11 likes Reading rather than contributing, but this is the most useful thread I have found on it.
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #17 · Evidence › Journal club · 11 Aug 2025 · 0 likes Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything…
-
Why catalogue breadth is not evidence of anything — what changed since Replied, post #15 · Compounds › Other compounds · 9 Aug 2025 · 8 likes Practical experience of catalogue breadth, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what make it…
-
About the Side effects category Replied, post #4 · Practice › Side effects · 8 Jul 2025 · 2 likes Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #20 · Practice › Reconstitution · 3 Jul 2025 · 0 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
-
Discussing something you have already been doing — the long version Started this topic · Clinical › Prescriber conversations · 2 Jul 2025 · 0 likes Discussing something you have already been doing — the long version Writing it up because I had to work it out twice and would rather nobody else did. A question about…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #92 · Practice › Reconstitution · 28 Jun 2025 · 0 likes Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all of them, writing the concentration on each vial in…
-
A ten-fold dose error caught before injection Replied, post #56 · Devices › Syringes & needles · 28 Jun 2025 · 32 likes Drawing air into the vial before withdrawing liquid equalises the pressure and makes the draw easier. It is not required and it is why some people find a full vial…
-
Repeatability versus intermediate precision Replied, post #75 · Analytics › Method validation · 27 Jun 2025 · 0 likes Confirming post #74 from a second method, which matters more than confirming it from a second person. Reporting a result to more decimal places than the method's…
-
Publishing an inconvenient result: a case study Replied, post #40 · Sourcing › Independent verification · 27 Jun 2025 · 2 likes This is the first time the answer has come with its own limits attached. Appreciated.
-
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #32 · Evidence › Journal club · 22 Jun 2025 · 30 likes Two claims get bundled together under STEP 4 and they need separating. The descriptive one — this is what was observed — is usually well supported. The causal one —…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #60 · Compounds › Cagrilintide & amylin analogues · 10 Jun 2025 · 5 likes Post #56 and I disagree about the size of the effect, not about the direction. Combination products complicate the certificate question considerably. Two active…
-
Coming back to: Getting a referral rather than a refusal Replied, post #42 · Clinical › Prescriber conversations · 7 Jun 2025 · 0 likes Prescribers reading this subcategory consistently say the most difficult consultations are the ones where information is withheld rather than the ones with difficult…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #45 · Evidence › Journal club · 5 Jun 2025 · 0 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #51 · Compounds › Cagrilintide & amylin analogues · 4 Jun 2025 · 5 likes Gastric emptying: both amylin and GLP-1 slow it, through partly overlapping but distinct mechanisms. Whether the slowing at a higher magnitude produces disproportionate…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #17 · Data & Tools › Calculators · 4 Jun 2025 · 0 likes Post #16 is right about the mechanism and I think understates the practical bit. What I would tell a new member reading about titration planner refuses for the first…
-
Why a pen's dose steps are fixed and what that costs you — one year on Replied, post #17 · Devices › Pens & autoinjectors · 3 Jun 2025 · 20 likes Right — I had this wrong and I am glad to have read it before it mattered.
-
Anxiety in the first weeks: drug, situation, or both Replied, post #96 · Wellbeing › Mental health · 1 Jun 2025 · 9 likes Adding the measurement that post #95 says would settle it. Nothing here is medical advice and several members in this subcategory say plainly that they are describing…
-
Reading a regulatory notice rather than an article about it — what changed since Replied, post #10 · Sourcing › Regulatory · 30 May 2025 · 1 like Regulatory positions change: a compound's status today might differ from its status a year from now. Citing a regulatory position is worth doing only with a date…
-
Revisiting: German, French and Dutch differences, compared Replied, post #27 · Regional › European Union · 30 May 2025 · 2 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
-
A well-designed study with a badly written abstract Replied, post #112 · Evidence › Study critique · 28 May 2025 · 17 likes That matches what I have seen, for whatever a single anecdote is worth.
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #77 · Practice › Reconstitution · 28 May 2025 · 0 likes Nothing to add on the substance. Thank you for taking the question at face value.
-
DXA precision and the least significant change for lean mass — the long version Replied, post #84 · Outcomes › Body composition · 23 May 2025 · 0 likes Everything in post #81 holds. The case it does not cover is the one I have. Absolute lean mass and lean mass as a proportion move differently and answer different…
-
Pregnancy as an absolute contraindication Replied, post #66 · Safety › Contraindications · 19 May 2025 · 20 likes Allergy to the specific compound: true allergy is rare but possible. Any prior allergic reaction to the same compound or to structurally similar peptides warrants…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #87 · Access › Pricing · 3 May 2025 · 6 likes Thank you — that answers what I came here to find out.
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #84 · Compounds › Cagrilintide & amylin analogues · 21 Mar 2025 · 0 likes Narrowing post #81, because the general version has more than one answer. Comparing an amylin analogue to an incretin agonist on weight change alone misses that they…
-
Reading a supplier's product description as a marketing document Replied, post #6 · Compounds › Other compounds · 20 Mar 2025 · 6 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
Follow-up: What other technical communities get right that we do not Replied, post #44 · Lounge › Off topic · 20 Mar 2025 · 0 likes Newer drugs and mechanisms: when a new drug launches or a new mechanism is discovered, the Lounge is a place to discuss the news and speculate before hard data exists.…
-
Journal club: STEP 4 and what a withdrawal design can prove — one year on Replied, post #41 · Evidence › Journal club · 3 Mar 2025 · 2 likes I had written a reply contradicting post #40 and deleted it. Here is what survived. STEP 4 has a well-known answer and a correct answer, and the interesting work is…
-
Second pass at: A single out-of-range value on an otherwise normal panel Replied, post #6 · Clinical › Bloodwork · 16 Feb 2025 · 0 likes Picking up post #5: that is the part I would want checked first. Lipid changes during substantial weight loss are expected and their trajectory is not always monotonic.…
-
Consistent declarations and why they matter more than clever ones Replied, post #32 · Sourcing › Logistics · 14 Feb 2025 · 5 likes Worth separating two things that post #28 runs together. Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country.…
-
[2026 update] Dose numbers across compounds are not on the same scale Replied, post #4 · Practice › Dosing & titration · 13 Feb 2025 · 32 likes The opening post describes the usual case. This is about the unusual one. The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly…
-
Scheduled maintenance and what will be unavailable Replied, post #40 · Meta › Announcements · 11 Feb 2025 · 1 like Post #38 put the caveat in the right place and I want to underline it. The bit of scheduled maintenance that nobody enjoys is that the answer changes depending on what…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #61 · Compounds › Cagrilintide & amylin analogues · 5 Feb 2025 · 10 likes The interest in combining it with semaglutide is that two different satiety mechanisms might add. Whether they do, and by how much, is exactly what the combination…
-
Specification in the result column: why that is a meaningful error — the long version Replied, post #9 · Analytics › COA interpretation · 19 Jan 2025 · 0 likes "Not less than 98 per cent" is a specification. "98.3 per cent" is a result. A certificate carrying only the first has not told you what was measured. Not a conclusion.…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #34 · Devices › Cold chain · 10 Jan 2025 · 0 likes The honest answer on Domestic fridge temperature mapping is that it depends, and the useful part is the list of what it depends on. Four items, in rough order of how…
-
Fixed versus detachable needles: the trade-offs Replied, post #84 · Devices › Syringes & needles · 1 Jan 2025 · 0 likes On fixed versus detachable needles: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable…
-
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #61 · Compounds › Semaglutide · 30 Dec 2024 · 0 likes Post #58 is right about the mechanism and I think understates the practical bit. Small correction to my own earlier position on Semaglutide formulation. I had the units…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #75 · Compounds › Oral incretins · 27 Dec 2024 · 5 likes The gastrointestinal tolerability profile of the oral formulation is broadly similar in character to the injectable, which supports the effects being systemic rather…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #23 · Compounds › Semaglutide · 19 Dec 2024 · 0 likes The version of Molecular mass of semaglutide that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under which…
-
Reading a supplementary appendix and finding the interesting part Replied, post #47 · Evidence › Trials · 19 Dec 2024 · 8 likes Clear enough that I do not think I have a follow-up, which is unusual.
-
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #51 · Nutrition & Training › Protein & intake · 11 Dec 2024 · 19 likes The mechanism is not mysterious. Substantial energy restriction with inadequate protein and no resistance stimulus loses lean tissue as well as fat. The right answer…
-
[2026 update] How to read a forest plot, properly, from scratch Replied, post #15 · Evidence › Trials · 4 Dec 2024 · 0 likes Coming back to post #14, because the follow-up matters more than the original answer. A treatment-policy estimand asks what happens to people assigned to a strategy,…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #110 · Analytics › COA interpretation · 8 Nov 2024 · 0 likes I changed my mind about field-by-field walk through a certificate after someone here asked me for the source and I could not produce one. That is worth saying out loud…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #23 · Compounds › Tirzepatide · 5 Nov 2024 · 21 likes Post #21 put the caveat in the right place and I want to underline it. Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent…
-
Time to steady state after a dose increase Replied, post #68 · Pharmacology › Pharmacokinetics · 4 Nov 2024 · 0 likes The time to maximum concentration after a subcutaneous dose in this class is measured in days rather than hours, which surprises people expecting an injection to act…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #119 · Clinical › Comorbidities · 28 Oct 2024 · 4 likes Hypertension improvement is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth twenty…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #71 · Compounds › Other compounds · 25 Oct 2024 · 15 likes Melanocortin agonists looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.
-
Levothyroxine timing: a real interaction with a simple fix Replied, post #2 · Practice › Interactions · 9 Oct 2024 · 2 likes Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as…
-
Why a preprint's supplementary material is often the best part Replied, post #43 · Evidence › Preprints · 29 Sep 2024 · 10 likes Check whether it was later published: searching for the preprint's first author and keywords in PubMed might find a published version. The published version is the…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #72 · Sourcing › Independent verification · 20 Sep 2024 · 0 likes PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual analytical results and verification records assessed over…
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #94 · Nutrition & Training › Hydration & electrolytes · 14 Sep 2024 · 0 likes Reduced intake reduces electrolyte intake alongside everything else, which is the mechanism behind most of what gets attributed to the compound here. If anyone has run…
-
The C-cell question: rodent findings and their human context — what changed since Replied, post #31 · Compounds › Semaglutide · 1 Sep 2024 · 0 likes Taking post #29 at face value and following it one step further. C-cell question is worth one more sentence than it usually gets, and the sentence is the one about how…
-
Circumference measurements as a poor man's composition estimate Replied, post #55 · Outcomes › Body composition · 10 Aug 2024 · 18 likes An honest declaration on circumference measurements: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than…
-
Guidelines revision: what changed and why Replied, post #54 · Meta › Announcements · 26 Jul 2024 · 8 likes Post #52 put the caveat in the right place and I want to underline it. A methods point on guidelines revision rather than a substantive one: if the comparison is not…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #73 · Compounds › Retatrutide · 21 Jul 2024 · 28 likes Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is not established is whether the tolerability profile differs from…
-
Mean kinetic temperature explained without the mathematics Started this topic · Practice › Storage & stability · 12 Jul 2024 · 14 likes Posting this under the heading it deserves: Mean kinetic temperature explained without the mathematics Everything below is what sits behind that. Two things I would…
-
Assessing a warm arrival: the decision process — one year on Replied, post #110 · Sourcing › Logistics · 1 Jun 2024 · 2 likes Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some jurisdictions are quite permissive; others are not.…